The transdermal delivery of fentanyl

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 84, Issue 3, 2013, Pages 449-455

  Lane, Majella E ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Fentanyl; Matrix; Pharmacokinetics; Reservoir; Transdermal patch

Indexed keywords

ADHESIVE AGENT; ALCOHOL; ALOE VERA EXTRACT; DESPROPIONYLFENTANYL; DRUG METABOLITE; DUROGESIC DTRANS; ETHYLENE VINYL ACETATE COPOLYMER; FENCINO; FENTALIS; FENTANYL; HYDROXYETHYLCELLULOSE; HYDROXYFENTANYL; HYDROXYNORFENTANYL; MATRIFEN; MORPHINE; NORFENTANYL; PETHIDINE; POLYMER; PROPYLENE GLYCOL; ROSIN; SILICONE; UNCLASSIFIED DRUG;

ANESTHESIA INDUCTION; AREA UNDER THE CURVE; BIOEQUIVALENCE; CANCER PAIN; CHRONIC PAIN; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE ESCALATION; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG TRANSFORMATION; DRUG WITHDRAWAL; EQUIPMENT DESIGN; ERYTHEMA; HEAT; HEAT TREATMENT; HUMAN; IONTOPHORESIS; MAXIMUM PLASMA CONCENTRATION; PLASMA PROTEIN BINDING; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRURITUS; RESERVOIR; RESPIRATION DEPRESSION; REVIEW; SKIN PERMEABILITY; TECHNOLOGY; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSDERMAL PATCH; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, CUTANEOUS; ANALGESICS; ANALGESICS, OPIOID; BUPRENORPHINE; CLINICAL TRIALS AS TOPIC; DRUG DELIVERY SYSTEMS; DRUG INDUSTRY; FENTANYL; HUMANS; PAIN; PHARMACEUTICAL PREPARATIONS; SKIN; TEMPERATURE; TIME FACTORS; TRANSDERMAL PATCH;

EID: 84879114355     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.01.018     Document Type: Review

References (46)

1. P.A. Janssen A review of the chemical features associated with strong morphine-likeactivity Br. J. Anaesth. 34 1962 260 268
2. Fentanyl A.C. Moffat, M.D. Osselton, B. Widdop, Clarke's Analysis of Drugs and Poisons 3rd ed. 2004 The Pharmaceutical Press London, United Kingdom 1029 1030
3. L.E. Mather Clinical pharmacokinetics of fentanyl and its newer derivatives Clin. Pharmacokinet. 8 1983 422 446
4. E. Nilsson Origin and rationale of neurolept analgesia Anaesthesiology 24 1963 267 268
5. U. Aromaa, K. Korttila, and T. Tammisto The role of diazepam and fentanyl in the production of balanced anaesthesia Acta Anaesthesiol. Scand. 24 1980 36 40
6. T. Tammisto, U. Aromaa, and K. Korttila The role of thiopental and fentanyl in the production of balanced anaesthesia Acta Anaesthesiol. Scand. 24 1980 31 35
7. A.S. Michaels, S.K. Chandrasekaran, and J.E. Shaw Drug permeation through human skin: theory and in vitro experimental measurement AIChE J. 21 1975 985 996
8. C.C. Hug Pharmacokinetics and dynamics of narcotic analgesics C. Prys-Roberts, C.C. Hug, Pharmacokinetics of Anaesthesia 1984 Blackwell Oxford 187 234
9. D.A. McClain, and C.C. Hug Intravenous fentanyl kinetics Clin. Pharmacol. Ther. 28 1980 106 114
10. T. Tateishi, Y. Krivoruk, Y.-F. Ueng, A.J.J. Wood, F.P. Guengerich, and M. Wood Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation Anest. Analg. 82 1996 167 172
11. T. Goromaru, H. Matsuraa, N. Yoshimura, T. Miyawaki, T. Sameshima, J. Miyao, T. Furuta, and S. Baba Identification and quantitative determination of fentanyl metabolites in patients by gas chromatography-mass spectrometry Anesthesiology 61 1984 73 77
12. H.H. Van Rooy, M.P. Vermeulen, and J.G. Bovill The assay of fentanyl and its metabolites in plasma of patients using gas chromatography with alkali flame ionisation detection and gas chromatography-mass spectrometry J. Chromatogr. 223 1981 85 93
13. J.H. Silverstein, M.F. Rieders, M. McMullin, S. Schulman, and K. Zahl An analysis of the duration of fentanyl and its metabolites in urine and saliva Anesth. Analg. 76 1993 618 621
14. R.F. Cookson Analgesic plasma concentrations Br. J. Anaesth. 52 1980 52-52
15. W.D. White, D.J. Pearce, and J. Norman Postoperative analgesia: a comparison of intravenous on-demand fentanyl with epidural bupivacaine Br. Med. J. 2 1979 166 167
16. M.J. Wolfe, and G.K. Davies Analgesic action of extradural fentanyl Br. J. Anaesth. 52 1980 357 358
17. L.E. Mather, and G.D. Phillips Opioids and adjuvants: principles of use M.J. Cousins, G.D. Phillips, Acute Pain Management 1986 Churchill Livingstone New York 77 103
18. S.D. Roy, and G.L. Flynn Solubility and related physicochemical properties of narcotic analgesics Pharm. Res. 5 1988 580 586
19. S.D. Roy, and G.L. Flynn Solubility behavior of narcotic analgesics in aqueous media: solubilities and dissociation constants of morphine, fentanyl, and sufentanil Pharm. Res. 6 1989 147 151
20. S.D. Roy, and G.L. Flynn Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin Pharm. Res. 6 1989 825 832
21. H.A. Daynes The process of diffusion through a rubber membrane Proc. Roy. Soc. Ser. A 97 1920 286 307
22. R.M. Barrer, and E.K. Rideal Permeation, diffusion and solution of gases in organic polymers Trans. Faraday Soc. 35 1939 628
23. S.D. Roy, and G.L. Flynn Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil Pharm. Res. 7 1990 842 847
24. D.J. Duthie, D.J. Rowbotham, R. Wyld, P.D. Henderson, and W.S. Nimmo Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients Br. J. Anaesth. 60 1988 614 618
25. F.O. Holley, and C. van Steenis Postoperative analgesia with fentanyl: pharmacokinetics and pharmacodynamics of constant-rate I.V. and transdermal delivery Br. J. Anaesth. 60 1988 608 613
26. J.R. Varvel, S.L. Shafer, S.S. Hwang, P.A. Coen, and D.R. Stanski Absorption characteristics of transdermally administered fentanyl Anaesthesiology 70 1989 928 934
27. S.K. Gupta, M. Southam, R. Gale, and S.S. Hwang System functionality and physicochemical model of fentanyl transdermal system J. Pain Symptom Manage. 7 1992 S17 S26
28. R.K. Portenoy, M.A. Southam, S.K. Gupta, J. Lapin, M. Layman, C.E. Inturrisi, and K.M. Foley Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics Anesthesiology 78 1993 36 43
29. T.S. Shomaker, J. Zhang, and M.A. Ashburn Assessing the impact of heat on the systemic delivery of fentanyl through the transdermal fentanyl delivery system Pain Med. 1 2000 225 230
30. M.A. Ashburn, L.L. Ogden, J. Zhang, G. Love, and S.V. Basta The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat J. Pain. 4 2003 291 297
31. FDA Public Health Advisory, Safety Warnings Regarding Use of Fentanyl Transdermal (skin) Patches. < http://www.fda.gov/cder/drug/advisory/fentanyl. htm >, (accessed July 2007).
32. K. Luckenbill, J. Thompson, O. Middleton, J. Kloss, and F. Apple Fentanyl post-mortem redistribution: preliminary findings regarding the relationship among femoral blood and liver and heart tissue concentrations J. Anal. Toxicol. 32 2008 639 643
33. K.N. Olson, K. Luckenbill, J. Thompson, O. Middleton, R. Geiselhart, K.M. Mills, J. Kloss, and F.S. Apple Postmortem redistribution of fentanyl in blood Am. J. Clin. Pathol. 133 2010 447 453
34. H. Andresen, A. Gullans, M. Veselinovic, S. Anders, A. Schmoldt, S. Iwersen-Bergmann, and A. Mueller Fentanyl: toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application J. Anal. Toxicol. 36 2012 182 194
35. G. Oliveira, J. Hadgraft, and M.E. Lane Toxicological implications of the delivery of fentanyl from gel extracted from a commercial transdermal reservoir patch Toxicol. in Vitro. 26 2012 645 648
36. S.D. Roy, M. Gutierrez, G.L. Flynn, and G.W. Cleary Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design J. Pharm. Sci. 85 1996 491 495
37. R. Miguel, J.M. Kreitzer, D. Reinhart, P.S. Sebel, J. Bowie, G. Freedman, and J.B. Eisenkraft Postoperative pain control with a new transdermal fentanyl delivery system Anesthesiology 83 1995 470 477
38. P. Fiset, C. Cohane, S. Browne, S.C. Brand, and S.L. Shafer Biopharmaceutics of a new transdermal fentanyl device Anesthesiology 83 1995 459 469
39. G. Sathyan, C. Guo, K. Sivakumar, S. Gidwani, and S. Gupta Evaluation of the bioequivalence of two transdermal fentanyl systems following single and repeat applications Curr. Med. Res. Opin. 21 2005 1961 1968
40. K.T. Moore, H.D. Adams, J. Natarajan, J. Ariyawansa, and H.M. Richards Bioequivalence and safety of a novel fentanyl transdermal matrix system compared with a transdermal reservoir system J. Opioid Manage. 7 2011 99 107
41. K.T. Moore, G. Sathyan, U. Richarz, J. Natarajan, and J. Vandenbossche Randomized 5-treatment crossover study to assess the effects of external heat on serumfentanyl concentrations during treatment with transdermal fentanyl systems J. Clin. Pharmacol. 52 2012 1174 1185
42. P.I. Hair, G.M. Keating, and K. McKeage Transdermal matrix fentanyl membrane patch (matrifen): in severe cancer-related chronic pain Drugs 68 2008 2001 2009
43. A. Boucaud, L. Machet, B. Arbeille, M.C. Machet, M. Sournac, A. Mavon, F. Patat, and L. Vaillant In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin Int. J. Pharm. 228 2001 69 77
44. P. Santos, A.C. Watkinson, J. Hadgraft, and M.E. Lane Formulation issues associated with transdermal fentanyl delivery Int. J. Pharm. 416 2011 155 159
45. B. Schröder, U. Nickel, E. Meye, and G. Lee Transdermal delivery using a novel electrochemical device, Part 1: Device design and in vitro release/permeation of fentanyl J. Pharm. Sci. 101 2012 245 255
46. B. Schröder, U. Nickel, E. Meye, and G. Lee Transdermal delivery using a novel electrochemical device, Part 2: In vivo study in humans J. Pharm. Sci. 101 2012 2262 2268